GraftWorx

- COVID-19 has highlighted the need for remote, at-home care for vulnerable populations. GraftWorx has accelerated commercial launch in response to this unprecedented situation and is actively seeking talent who can help us deliver solutions for the pandemic by this summer.

- GraftWorx has developed an all-in-one solution for remote cardiovascular monitoring, a $40B opportunity.

- We enable health systems to achieve their clinical quality goals for remote patient management with a single, wearable remote monitoring platform.

- GraftWorx brings hospital-grade monitoring into the home in a wireless, wearable, form factor. The system has been validated on over 200 patients and has been launched with the National Health Services (NHS) to provide remote monitoring for dialysis patients

- GraftWorx has also secured commercial partnerships with four dialysis providers, an integrated healthcare system, and the US military.